We are live on
!
Find out more
ORI
Oak Ridge Investments Portfolio holdings
AUM
$1.77B
1-Year Est. Return
63.16%
This Fund
S&P 500
This Quarter
Est. Return
+12.95%
1 Year Est. Return
+63.16%
3 Year Est. Return
+207.98%
5 Year Est. Return
+285.85%
10 Year Est. Return
+1,406.08%
AUM
$2.1B
AUM Growth
-$366M
(-15%)
Cap. Flow
-$558M
Cap. Flow
% of AUM
-26.61%
Top 10 Holdings %
Top 10 Hldgs %
21.05%
Holding
173
New
14
Increased
15
Reduced
123
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADSW
Advanced Disposal Services Inc
ADSW
|
+$17.4M |
| 2 |
Corcept Therapeutics
CORT
|
+$10.2M |
| 3 |
AET
Aetna Inc
AET
|
+$7.65M |
| 4 |
PayPal
PYPL
|
+$7.42M |
| 5 |
Netflix
NFLX
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$37.8M |
| 2 |
Criteo
CRTO
|
+$32M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$24.2M |
| 4 |
AKRX
Akorn Inc
AKRX
|
+$23M |
| 5 |
CELG
Celgene Corp
CELG
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.28% |
| 2 | Technology | 20.83% |
| 3 | Industrials | 18.26% |
| 4 | Consumer Discretionary | 14.4% |
| 5 | Financials | 6.68% |
Similar funds
CGH
KOCAA
SW
GD
HHAM
FFS
SLF
NMC
Oak Ridge Investments's Q4 2017 Portfolio in Review
As of Q4 2017, Oak Ridge Investments held 173 positions worth $2.1B, down 15% from $2.46B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Oak Ridge Investments withdrew a net $558M in Q4 2017, closing 9 positions and reducing 123 holdings. Its most notable exit was Criteo, an estimated $32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, Oak Ridge Investments opened a new position in Corcept Therapeutics worth $10.1M.
- Oak Ridge Investments's largest Q4 2017 buy was Corcept Therapeutics: 561,054 shares worth $10.1M.
- Oak Ridge Investments added most to Advanced Disposal Services Inc in Q4 2017, an estimated $17.4M increase.
- Oak Ridge Investments's biggest Q4 2017 reduction was Sage Therapeutics, cutting an estimated $37.8M.
- Oak Ridge Investments fully exited Criteo in Q4 2017, selling an estimated $32M.
- Oak Ridge Investments's ten largest holdings make up 21% of its $2.1B portfolio in Q4 2017.
- Oak Ridge Investments opened 14 new positions and closed 9 in Q4 2017.
- Oak Ridge Investments's portfolio value fell 15% quarter-over-quarter to $2.1B.
Based on Oak Ridge Investments's 13F filing for Q4 2017, filed 13 Feb 2018.